Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Humana Interim / Quarterly Report 2021

May 6, 2021

3059_10-q_2021-05-06_c13fa6b1-30b7-4d43-ba9f-8bb16f5c5f9c.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Interim report January-March, Q1 2021

Continued good progress in first quarter

First quarter, January–March 2021

  • Operating revenue was SEK 1,986m (1,938), an increase of 2%. Organic growth was 2.4%.
  • Operating profit was SEK 112m (98), an increase of 14%.
  • Net profit after tax for the period amounted to SEK 63m (53).
  • Basic and diluted earnings per share for the period amounted to SEK 1.27 (1.00).
  • Operating cash flow amounted to SEK 197m (95).

Significant events in and after the end of the quarter

  • In February, Humana acquired the Swedish individual and family company Team J-son. Team J-son's annual revenue is approximately SEK 90m and the company has about 120 employees.
  • In February and March 2021, Humana repurchased 2,357,348 shares at a cost of SEK 159m, corresponding to an average price of SEK 67.51 per share. Subsequently, the company's total own shareholding amounts to 5,017,059 shares, which is 9.44 percent of the total number of outstanding shares and votes.
  • Humana's Board proposes to the 2021 AGM, to be held on 11 May, that no dividend be paid for the 2020 financial year.

Key ratios

SEK millions Jan–Mar
2021
Jan–Mar
2020
% Apr–Mar
2020/21
Jan–Dec
2020
%
Net revenue 1,984 1,932 3% 7,822 7,771 1%
Other operating
revenue
2 6 -64% 22 26 -14%
Operating revenue 1,986 1,938 2% 7,845 7,797 1%
Operating profit 112 98 14% 485 471 3%
Adjusted operating
profit
112 98 14% 467 453 3%
Net profit for the period 63 53 18% 271 262 4%
Operating cash flow 197 95 107% 881 779 31%

CEO Comment

We see a clear and positive effect from the vaccinations. At the same time, vaccination is not a magic bullet, so the systematic preventive efforts linked to the pandemic must continue.

The first quarter of the year was a stable one. The vaccination of our personnel and customers has improved our operational situation and the Humana Group continued to grow organically. Profitability was good with increased operating profit in four out of five business areas and our cash flow was strong.

Revenue amounted to SEK 1,986m in the first quarter and organic growth was 2.4 percent. The Individual & Family, Personal Assistance and Norway business areas were drivers behind this growth. At the same time, the pandemic had a negative impact on revenue due to lower occupancy in elderly care in Sweden and Finland and outpatient care in Finland. Operating profit amounted to SEK 112m, an increase of 14 percent compared with the same quarter last year thanks to higher profit in all business areas except Finland, which faced several parallel challenges. Operating profit together with a decrease in working capital helped to strengthen cash flow in the quarter, which in turn provided scope to repurchase additional shares. Even after these transactions, Group debt was in line with our target at the end of the quarter.

Strong organic growth in Norway

At the business area level, Norway stood out with organic growth of 11.2 percent. The new agreement in the assistance operations led to new customers and explains some of the growth. The segment for care homes is also growing. It is also worth noting that when it comes to our operations in Norway, the Hagen report on private welfare providers was published in December after two years of work. It will

contribute facts and knowledge to the debate on private welfare providers. The report acknowledges the role played by private welfare providers and shows that funds allocated to welfare is reaching the end users and that profit margins are reasonable, but it also highlights the importance of competence on the part of the contractors. The report is well worth reading by anyone interested in the future of welfare in the Nordics and the challenges it faces.

Newly established operations contribute

During the quarter, the Individual & Family business area noted its highest organic growth for an individual quarter in several years: 3.6 percent. The new operations in LSS and the adult segment are contributing, while demand in the child and youth segment remains stable. During the quarter, Individual & Family also acquired a company and we welcomed Team J-son in February, a provider of highquality care services for children and adolescents with complex needs with annual sales of SEK 90m.

Growth was also good in Personal Assistance for the quarter. The business area grew by 5 percent and also received high marks in our internal quality measurements thanks to good results in both the employee satisfaction survey as well as our customer satisfaction survey.

The Finnish operation is headed in the right direction operationally but faces several challenges. Both revenue and operating profit decreased in the quarter. The pandemic continues to have a negative effect on revenue due to lower occupancy in elderly and outpatient care. The reduction in revenue is also an effect of previous closings of units. In short, there remain financial challenges in Finland but the new management team has closed in on the problems and is now fully focused on taking corrective measures.

Pandemic remains main focus

Unfortunately, this is the fifth quarterly report in which I must state that the pandemic continues to be the main focus of our day-to-day activities, especially in elderly care. Since our elderly care residents as well as our employees have had the opportunity to be vaccinated, we see a clear and positive effect from the vaccinations. At the same time, vaccination is not a magic bullet, so the systematic preventive efforts linked to the pandemic in our operations must continue. The virus continues to spread in socitey as this is being written, so we must remain extra cautious. It is crucial that we not get distracted now. Our employee surveys show that the year has been challenging for our employees in elderly care, which underlines how important it is with a well-working and accessible leadership. That being said, there is also a lot of positive energy being generated in the operations. After the end of the quarter, in early April, the new elderly care home in Falkenberg opened and we welcomed many residents already in

the first month. In May and June we will open three more elderly care homes, in Vallentuna, Ängelhom and Norrtälje.

Humana's sustainability work gets attention

Finally, I would also like to recommend a look at our 2020 Annual and Sustainability Report, which was published in early April, and especially our expanded Sustainability Report. We have a lot left to do in the area of sustainability but also much to be proud of. The latter was confirmed by the Sustainable Brand Index, which is the largest independent brand study focused on sustainability in Europe and describes how consumers feel about a company's sustainability performance. It ranks Humana as the most sustainable brand in the health care providers category in Sweden for 2021. This pleases us but also places expectations on us.

Stockholm, 6 May 2021

Rasmus Nerman President and CEO, Humana AB

This is Humana

We drive the future of welfare

Humana is there for people with functional impairment, psychosocial disorders and mental illness and for the elderly. Our vision is Everyone is entitled to a good life. With assignments in hundreds of municipalities, 9,000 customers and clients, over 16,000 employees and several hundred units in Sweden, Finland, Norway and Denmark, we are a major provider in Nordic welfare. Humana manifests what quality care is all about. Our work is based on the individual's circumstances and needs. And our care is grounded in scientific evidence and the best available know-how, and is provided by knowledgeable, dedicated employees. Both our own and external surveys confirm that we succeed in what we do time and time again. But we won't stop there. Continuous development to maintain the highest quality is an essential aspect for us. We intend to set a new, higher standard of care. This is how we drive the future of Nordic care and welfare.

Everyone is entitled to a good life. Humana works to make this a reality.

Five business areas Operations in four countries

Strong market position in the Nordics

Humana is a Nordic care group with market-leading positions in individual and family care and personal assistance. We are growing in elderly care and are building new care homes under our own management.

16,717 employees 8,795

customers

7,797 revenue, SEK millions

Strategy for sustainable care

Humana's vision and overall objective deal with sustainability at an individual and societal level. Therefore, sustainability is an integral part of our strategy.

We have defined four strategic target areas: quality, attractiveness as an employer, profitable growth and social responsibility. These target areas, together with our core values, steer our business towards the vision that everyone is entitled to a good life.

OBJECTIVE

The obvious provider of care services for customers, clients and contractors with requirements for high quality.

STRATEGIC TARGET AREAS

QUALITY OPERATIONS ATTRACTIVE EMPLOYER

PROFITABLE GROWTH

Financial overview

Operating revenue by business area

SEK millions Jan–Mar
2021
Jan–Mar
2020
% Apr–Mar
2020/21
Jan–Dec
2020
%
Individual & Family 553 519 6% 2,135 2,101 2%
Personal Assistance 751 719 5% 2,963 2,931 1%
Elderly Care 151 146 3% 612 608 1%
Finland 316 350 -10% 1,293 1,327 -3%
Norway 210 194 8% 804 788 2%
Other 1) 5 10 -50% 38 43 -11%
Total operating revenue 1,986 1,938 2% 7,845 7,797 1%

Organic growth by business area

Percent Jan–Mar
2021
Jan–Mar
2020
Apr–Mar
2020/21
Jan–Dec
2020
Individual & Family 3.6% 1.4% 1.0% 0.4%
Personal Assistance 2.5% 2.9% 4.0% 4.1%
Elderly Care 3.1% 9.0% 6.3% 7.7%
Finland -4.6% 10.2% -2.5% 7.4%
Norway 11.2% 4.6% 10.9% 8.9%
Total organic growth 2.4% 3.8% 2.9% 4.1%

Operating profit by business area

SEK millions Jan–Mar
2021
Jan–Mar
2020
% Apr–Mar
2020/21
Jan–Dec
2020
%
Individual & Family 41 33 24% 198 190 4%
Personal Assistance 50 40 23% 169 160 6%
Elderly Care 5 0 n/a 16 10 59%
Finland 11 17 -32% 56 62 -8%
Norway 17 13 28% 72 69 5%
Other 1) -12 -5 -140% -27 -20 -35%
Total operating profit 112 98 14% 485 471 3%

Operating margins by business area

Percent Jan–Mar
2021
Jan–Mar
2020
Apr–Mar
2020/21
Jan–Dec
2020
Individual & Family 7.5% 6.4% 9.3% 9.0%
Personal Assistance 6.6% 5.6% 5.7% 5.5%
Elderly Care 3.6% -0.3% 2.6% 1.6%
Finland 3.6% 4.7% 4.4% 4.6%
Norway 7.9% 6.7% 9.0% 8.7%
Total operating margin 5.7% 5.1% 6.2% 6.0%

1) Operating revenue and operating profit for the second quarter of 2020 include capital gain on sale of properties of SEK 17m.

Group development

Revenue

Operating revenue amounted to SEK 1,986m (1,938) in the first quarter, an increase of 2%. The organic revenue growth was 2.4% (3.8) for the quarter. Adjusted for leap day, organic growth amounted to 3.5% (2.7) in the first quarter. Improved organic growth in the Individual & Family and Norway business areas explain the organic growth.

Acquired operations accounted for SEK 29m of revenue. Operations under own management accounted for 94% of total revenue in the quarter and contracted operations accounted for 6%.

The Covid-19 pandemic had a negative impact on revenue largely due to lower occupancy in elderly care in Sweden and Finland and outpatient care in Finland.

Profit

Operating profit for the first quarter totaled SEK 112m (98), an increase of 14%. The operating margin was 5.7% (5.1). The improvement in profit and margin compared to the same period last year is attributable to all business areas except for Finland, which despite progress, did not contribute to the profit and margin increase.

The Covid-19 pandemic has affected the Group from several aspects. Lower occupancy had a negative effect on revenue while increased sickness absences and increased use of PPE resulted in higher costs. The increased costs were offset by lower social security costs, government support for sickness absence and partial compensation for PPE.

The effect on operating profit of accounting standard IFRS 16, which has been applied since 1 January 2019, amounted to SEK 15m in the quarter (see table).

IFRS 16 effects, SEK millions Jan–Mar
2021
Jan–Mar
2020
Rental charges 88 85
Depreciation -73 -69
Operating profit 15 16
Net financial effect -20 -20
Profit before tax -5 -3

Operating cash flow and interest-bearing net debt

Operating cash flow in the first quarter amounted to SEK 197m (95). The increase is mostly attributable to improved profit, decreased working capital and lower investments.

Humana's interest-bearing net debt decreased by SEK 110m to SEK 3,688m (3,798). The decrease is mainly attributable to an increased operating cash flow offset by buyback of shares. The leverage ratio, i.e. interest-bearing net debt in relation to adjusted EBITDA, decreased to 4.4x (5.2), which means that Humana achieved the financial target.

In order to improve the capital structure, Humana repurchased shares of SEK 159m in the quarter. As of March 31, 2021, the holding of treasury shares amounts to 9.44% of the total number of outstanding shares corresponding to SEK 313m at cost. The repurchased shares have reduced cash and equity, which increases the company's interest-bearing net debt. In the future, the company's holding of own shares may ultimately be used as payment for or to finance acquisitions of companies and/or assets. They may also be cancelled.

Revenue

Operating profit

Performance by business area

Individual & Family

Revenue for the first quarter amounted to SEK 553m (519), an increase of 6% compared to the corresponding period last year. Organic growth was 3.6% (1.4). Adjusted for leap day, organic growth amounted to 4.8% (0.3) in the first quarter. Stable occupancy in the child and youth client group, increased occupancy in the adult segment, new units and acquisitions drove the revenue increase in the first quarter.

Operating profit for the first quarter totaled SEK 41m (33), an increase of 24% compared with the previous year. The operating margin for the first quarter was 7.5% (6.4). The increase in profit for the quarter is due to improved control and positive contributions from acquisitions. The increased costs associated with the Covid-19 pandemic in the quarter were compensated for by government grants.

Personal Assistance

Revenue increased by 5% to SEK 751m (719) in the first quarter. Organic growth was 2.5% (2.9). Adjusted for leap day, organic growth amounted to 3.6% (1.8) in the first quarter. Other than acquired operations, the revenue increase is mainly due to a higher attendance allowance.

Operating profit for the quarter totaled SEK 50m (40), an increase of 23%. The operating margin was 6.6% (5.6). The operating margin increased due to more efficient cost management and positive contributions from acquisitions.

Percentage of Group revenue Q1 2021

Operating revenue and operating margin

Percentage of Group revenue Q1 2021

Operating revenue and operating margin

Elderly Care

Revenue amounted to SEK 151m (146) in the first quarter. The 3% (9.0) increase is entirely organic. Adjusted for leap day, organic growth amounted to 4.3% (7.8) in the first quarter. The increase is due entirely to contracted operations. The pandemic had a negative effect on occupancy this quarter as well.

Operating profit in the first quarter amounted to SEK 5m (0). The operating margin was 3.6% (-0.3). Improvements in new units had positive effects.

The pandemic has affected the result through lower occupancy and higher costs for sick leave and PPE, personal protective equipment. The higher costs have been partially offset by government grants.

Finland

Revenue amounted to SEK 316m (350) in the first quarter, a decrease of 10%. Organic growth was -4.6% (10.2). Adjusted for leap day, organic growth amounted to -3.6% (9.0) in the first quarter. The decrease in revenue was impacted by terminated unprofitable contracts. The pandemic also had a negative impact in elderly care and outpatient care. New unit openings had a positive effect but did not fully compensate for the decrease in revenue.

Operating profit for the first quarter amounted to SEK 11m (17), a decrease of 32% compared to the corresponding period last year. The operating margin for the quarter was 3.6% (4.7). The lower profit for the quarter was partly driven by the negative effects of the pandemic on occupancy and increased costs for sick leave.

Percentage of Group revenue Q1 2021

Operating revenue and operating margin

Percentage of Group revenue Q1 2021

Operating revenue and operating margin

Norway

Revenue increased by 8% to SEK 210m (194) in the first quarter. Organic revenue growth was 11.2% (4.6) for the quarter. Adjusted for leap day, organic growth amounted to 12.5% (3.4) in the first quarter. The revenue increase and organic growth are mainly due to an increase in customers in personal assistance and the care home segment.

Operating profit for the quarter amounted to SEK 17m (13), a year-on-year increase of 28%. The operating margin for the quarter was 7.9% (6.7). The improved operating margin for the quarter is due to an increased number of customers and higher operational efficiency.

Percentage of Group revenue Q1 2021

Operating revenue and operating margin

Financial position

Financing

The Group's equity amounted to SEK 2,282m (2,368) on 31 March 2021. The equity/assets ratio was 28.3% (28.4). Interest-bearing net debt amounted to SEK 3,688m (3,798), a year-on-year decrease of SEK 110m. The leverage ratio, measured as interest-bearing net debt in relation to adjusted EBITDA, decreased to 4.4x (5.2). The decrease is mainly due to higher profit and fewer investments.

SEK millions 31 Mar 2021 31 Mar 2020 31 Dec 2020
Non-current interest-bearing liabilities 1,970 3,695 3,457
Current interest-bearing liabilities 2,307 892 813
Cash and cash equivalents -589 -789 -759
Interest-bearing net
debt
3,688 3,798 3,511
Equity/assets ratio 28.3% 28.4% 29.3%
Interest-bearing net debt/adjusted
EBITDA, 12 months, times
4.4x 5.2x 4.3x

Cash flow

Cash flow for the quarter amounted to SEK -196m (-58), where net cash flow from operating activities was SEK 169m (94). The higher cash flow from operating activities is mainly due to increased profit and decreased working capital compared to last year.

Cash flow from investing activities in the quarter amounted to SEK -82m (-31), of which SEK -59m related to acquisitions in the quarter, while the first quarter last year was affected positively by sale of real estate. Cash flow from financing activities was SEK -283m (-121). The change is due to the buyback of shares for SEK 159m.

Financial targets

Profitability

An operating margin of 7% over the medium term.

Revenue growth

Annual organic revenue growth of 5% over the medium term. Bolt-on acquisitions may generate additional annual growth of 2-3%.

Capital structure

Interest-bearing net debt not exceeding 4.5 times EBITDA, i.e. operating profit before depreciation, amortisation and impairment (see Financial definitions and intent). Debt may temporarily exceed the target level, which may happen during acquisitions.

Dividend policy

Payment of a dividend equivalent to 30% of net profit for the year. The proposed dividend shall consider Humana's long-term development potential and financial position.

Sustainability

Quality Report, first quarter, January–March 2021

Humana Quality Model and quality at Humana

Humana is convinced that quality needs to be measured and followed up. Measuring and following up helps to develop our operations and to always keep high quality in focus. To measure quality within the Group and be able to compare various operations and see changes over time, Humana has developed the Humana Quality Model (HQM). The model is built on two parallel approaches: seven quantitative indicators that are weighed together to form the Humana Quality Index (HQI) along with qualitative and quantitative following up of customers'/clients' individual plans and the personal goals that guide them. Both perspectives are equally important in creating an overall assessment of quality. Follow-ups are done quarterly. Humana has presented the quality report on our website since 2019.

Humana Quality Index

All business areas continue to work hard to prevent the spread of Covid-19 and we have managed to keep transmission at a low level. Vaccination is ongoing, and in both elderly care and LSS homes in Sweden, all residents who want the vaccine have received their second injection. Even so, we continue to maintain a high level of protection. The danger is not over, and we believe that we need to keep vigilant for a good while yet.

After six months at the record level of 95/100, the HQI for the Group at large decreased by one point during the quarter to 94/100, where 100 is the longterm target. The Personal Assistance business area increased its level by two points to a new record of 98/100 thanks to good results in the employee survey and the customer survey. At the same time, the levels of the Elderly Care and Finland business areas decreased somewhat due to lower results in the employee survey. After several years of good results in elderly care, the initial analyses indicate that the less favorable result is due to the exceptionally strenuous effects of the 2020 pandemic year. The year was strenuous both physically and mentally, and many were negatively affected by the mostly negative criticism directed at elderly care over the course of the year.

The number of serious deviations decreased during the quarter compared with the previous quarter. Three Lex Sarah and one Lex Maria case were submitted to the Health and Social Care Inspectorate (IVO).

Follow-up of individual plans

The number of individual plans that were followed up as scheduled was unchanged for the quarter at 85/100 compared with the previous quarter. This is a reduction compared with the full year result from 2020.

Here, there are also differences between business areas. Individual & Family increased slightly to 95/100 for the quarter, while the Norway business area decreased slightly from its record level of last autumn to a still high 93/100. Personal Assistance has a way to go yet to assure the individual plans and remains at the same level as last quarter: 71/100. Generally, the individual plans constitute an area that is important to continue improving.

It is important that an individual plan is prepared for all customers and clients. In Sweden this is called an implementation plan. We count the number of customers/clients who have an individual plan that has been prepared and followed up. The individual plan and its goals form the foundation of the quality control.

Humana Quality Index

Personal data breaches

Three personal data breaches were reported to the Swedish Authority for Privacy Protection (IMY) in the first quarter. No incidents were reported in other countries.

Everyone that comes into contact with Humana should feel that their personal data is secure with us. We are transparent about the data we handle and why. Read more about GDPR at Humana here:

https://www.humanagroup.com/media/gdpr-humana

Read about sustainability at Humana

Quality is one of the four strategic target areas that form the basis for Humana's sustainable care strategy. Other target areas are attractive employer, profitable growth and socially responsible provider, which includes environmental responsibility. Read more about Humana's sustainable strategy, our four strategic target areas and our sustainability work on our website at https://www.humanagroup.com/sustainability/

Other information

Employees

The number of full-time employees as of 31 March 2021 was 10,231 (9,997).

Shares, share capital and shareholders

The number of shares in Humana AB as per 31 March 2021 amounted to 53,140,064 with a quotient value of SEK 0.022, corresponding to share capital of SEK 1,180,879. The number of shareholders was 4,683. The five largest shareholders were Impilo Care AB, Incentive AS (via funds and mandate), SEB Investment Management, Alcur Fonder and Nordea Investment Funds.

Share buybacks

At the 2020 AGM, the Board was mandated to repurchase shares as long as the company's total holdings of own shares does not exceed one-tenth of all shares in the company and to transfer own shares in the company. In February and March 2021, Humana repurchased 2,357,348 shares at a cost of SEK 159m, corresponding to an average price of SEK 67.51 per share. Subsequently, the company's total own shareholding amounts to 5,017,059 shares, which is 9.44 percent of the total number of outstanding shares and votes. After repurchases, the total number of shares excluding the own holding amounts to 48,123,005.

Marketplace

Humana's shares trade on the Nasdaq Stockholm Main Market. The company's ticker symbol is HUM and the ISIN code is SE0008040653.

Share-based incentive programmes

Humana has no ongoing long-term share-related incentive programme for senior executives or other employees.

In June 2020, Impilo Care AB, Humana's principal owner, made an offer to Board members and senior executives of Humana to acquire synthetic options in Humana issued by Impilo Care AB. Humana did not participate in the offer and it will not give rise to any costs for Humana. A total of 461,000 synthetic options were acquired. The total market value of the options on the transaction date is estimated at approximately SEK 1.4m. The synthetic options are related to Humana's share and expire after three years. The options can be exercised from 1 April 2023 to 30 June 2023. The exercise price is SEK 77.90 per option.

Annual General Meeting

Humana's 2021 Annual General Meeting (AGM) will be held on Tuesday 11 May at 15:00 CET. Due to the extraordinary situation caused by the Covid-19 pandemic, the meeting will be held in a different manner than usual. To reduce the risk of transmission and considering official regulations and advice on avoidance of gatherings, the meeting will be held, supported by temporary statutory provisions, through absentee voting (postal voting). There will be no meeting in person or through a proxy, i.e., there will be no physical participation.

Dividend

Humana's Board proposes to the 2021 AGM that no dividend be paid for the 2020 financial year and that any profits be carried forward.

Annual and Sustainability Report

The 2020 Annual and Sustainability Report is available on Humana's website at https://www.humanagroup.com/

Related party transactions

The Group's key personnel consists of the Board of Directors, Group management and the CEO, through ownership of the company and through their roles as senior executives. Related party transactions are based on market conditions.

Risks and uncertainties

In the course of its operations, Humana is exposed to different types of financial risks, which can be divided into liquidity and funding risk, interest rate risk, credit risk and currency risk. Risks are described in more detail in the section in Humana's 2020 annual and sustainability report entitled Risks and risk management on pages 64–71 as well as in Note G20.

The main risks related to operations and uncertainties that can affect the company's performance are related to political decisions that may affect private care companies, as well as risks when implementing completed acquisitions. Humana conducts operations that are financed by state, municipal and regional entities, and as such, operations can be affected by political decisions. As a result, Humana's opportunities for growth are affected by public opinion and political views on the company's areas of operation. Humana is constantly monitoring the external situation. The purpose is to quickly perceive external changes in order to assess risks and opportunities, as well as adapt operations to external changes. The political situation is evaluated continuously.

Communicable diseases exist in society. These infections can affect anyone in society but the situation is most difficult for vulnerable persons. Humana's operations include customers and clients in vulnerable groups and there are guidelines and procedures in the company's management system on how to prevent and manage various communicable diseases. Communicable diseases may also lead to several employees getting sick at the same time, which entails a risk of not having enough qualified staff to meet needs. A pandemic also entails a risk of a negative impact on Humana's revenues and costs, for example as a result of lower occupancy or increased costs for sickness absences and PPE. Humana's operations are affected by the prevailing Covid-19 pandemic. A crisis management structure has been supporting the work of minimising transmission and impact since the pandemic began.

This interim report was not subject to a review as per ISRE 2410 by the company's auditors.

The President certifies that this interim report for the first quarter gives a true and fair presentation of the Parent Company's and Group's business, financial position and result of operations, and describes the material risks and uncertainties facing the Parent Company and the Group.

Stockholm, 6 May 2021

Rasmus Nerman President and CEO

Consolidated income statement

Jan–Mar Jan–Mar Apr–Mar Jan–Dec
SEK millions
Note
2021 2020 2020/21 2020
Net revenue 1,984 1,932 7,822 7,771
Other operating revenue 2 6 22 26
Operating revenue
3.4
1,986 1,938 7,845 7,797
Other external expenses -229 -240 -902 -913
Personnel costs 1,554 -1,511 -6,083 -6,039
Depreciation/amortisation -91 -88 -374 -371
Other operating expenses 0 -1 -2 -2
Operating expenses -1,874 -1,840 -7,360 -7,326
Operating profit 112 98 485 471
Financial income 2 4 4 6
Financial expenses -35 -38 -142 -145
Profit before tax 79 64 346 332
Income tax -16 -11 -75 -70
Net profit for the period 63 53 271 262
Attributable to:
Parent Company shareholders 63 53 271 262
Non-controlling interests - 0 0 0
Net profit for the period 63 53 271 262
Earnings per share, SEK, before dilution 1.27 1.00 5.21 4.94
Earnings per share, SEK, after dilution 1.27 1.00 5.21 4.94
Average number of shares, thousands 49,415 53,140 52,061 52,995

Consolidated statement of other comprehensive income

Jan–Mar Jan–Mar Apr–Mar Jan–Dec
2020
63 53 271 262
6 -24 5 10 39
49 5 -31 -74
87 63 251 227
87 63 251 227
- 0 0 0
Note 2021 2020 2020/21

Condensed consolidated balance sheet

SEK millions
Note
31 Mar 2021 31 Mar 2020 31 Dec 2020
Assets
Non-current assets
Goodwill 5
3,925
3,923 3,815
Other intangible assets 13 6 5
Property, plant and equipment 322 391 314
Right-of-use assets 2,130 2,141 2,119
Financial assets 43 37 42
Total non-current assets 6,434 6,497 6,295
Current assets
Trade receivables and other receivables 865 838 852
Other current receivables 165 215 138
Cash and cash equivalents 589 789 759
Total current assets 1,619 1,842 1,749
TOTAL ASSETS 8,052 8,340 8,044
Equity and liabilities
Equity
Share capital 1 1 1
Other paid-in equity 1,096 1,096 1,096
Reserves 19 38 -6
Retained earnings 1,167 1,211 1,264
Equity attributable to Parent Company shareholders 2,282 2,346 2,354
Equity attributable to non-controlling interests - 22 -
Total equity 2,282 2,368 2,354
Non-current liabilities
Non-current lease liabilities 1,970 1,959 1,958
Other interest-bearing liabilities - 1,736 1,499
Deferred tax liabilities 72 71 70
Total non-current liabilities 2,042 3,766 3,527
Current liabilities
Current lease liabilities 236 271 232
Other interest-bearing liabilities 2,071 620 581
Trade payables 111 91 128
Other current liabilities 6
1,310
1,223 1,222
Total current liabilities 3,728 2,206 2,163
TOTAL EQUITY AND LIABILITIES 8,052 8,340 8,044

Condensed consolidated statement of changes in equity

Equity
attributable to
Other Parent Non
SEK millions Share
capital
paid-in
capital
Translation
reserve
Retained
earnings
Company
shareholders
controlling
interests
Total
equity
Opening balance, 1 Jan 2020 1 1,096 29 1,158 2,284 22 2,305
Comprehensive income for the
period
Net profit for the period - - - 53 53 0 53
Other comprehensive income for the
period
- - 10 - 10 - 10
Total comprehensive income for the
period
- - 10 53 63 0 63
Closing balance, 31 Mar 2020 1 1,096 38 1,211 2,346 22 2,368
Opening balance, 1 Jan 2021 1 1,096 -6 1,264 2,354 - 2,354
Comprehensive income for the
period
Net profit for the period - - - 63 63 - 63
Other comprehensive income for the
period
- - 25 - 25 - 25
Total comprehensive income for
the period
- - 25 63 88 - 88
Owner transactions
Share buybacks - - - -159 -159 - -159
Total owner transactions - - - -159 -159 - -159
Closing balance, 31 Mar 2021 1 1,096 19 1,167 2,282 - 2,282

Condensed consolidated statement of cash flows

SEK millions Note Jan–Mar 2021 Jan–Mar 2020 Apr–Mar 2020/21 Jan–Dec 2020
Profit before tax 79 64 346 332
Adjustments for:
Depreciation/amortisation 91 88 374 371
Financial items, net 33 34 138 139
Capital gain on sale of property, plant and
equipment
-1 0 -19 -17
Cash flow from operating activities
before change in working capital
202 187 839 824
Change in working capital 23 -41 134 71
Cash flow from operating activities 225 146 973 895
Financial items paid, net -30 -30 -144 -143
Income tax paid -26 -23 -93 -90
Net cash flow from operating activities 169 94 736 661
Acquisition of subsidiaries, net cash impact 5 -59 0 -77 -18
Disposal of properties 6 20 101 114
Investments in other non-current assets, net -29 -51 -111 -133
Cash flow from investing activities -82 -31 -87 -37
Loans raised 0 0 23 24
Repayment of borrowings -50 -50 -251 -251
Repayment of lease liability -73 -71 -287 -284
Share buybacks -159 - -315 -156
Cash flow from financing activities -283 -121 -829 -667
Cash flow for the period -196 -58 -180 -42
Cash and cash equivalents, opening
balance
759 836 789 836
Exchange rate difference in cash and cash
equivalents
26 11 -21 -35
Cash and cash equivalents, closing
balance
589 789 589 759

Key ratios

Jan–Mar 2021 Jan–Mar 2020 Apr–Mar 2020/21 Jan–Dec 2020
Operating revenue 1,986 1,938 7,845 7,797
Operating margin, % 5.7% 5.1% 6.2% 6.0%
Interest-bearing net debt, SEKm 3,688 3,798 3,688 3,511
Return on capital employed, % 1.7% 1.4% 7.4% 7.1%
Equity/assets ratio, % 28.3% 28.4% 28.3% 29.3%
Operating cash flow, SEKm 197 95 881 779
Interest-bearing net debt/adjusted EBITDA, 12
months, times
4.4x 5.2x 4.4x 4.3x
Average number of full-time employees, Individual
and Family
2,105 2,085 2,070 2,065
Average full-time employees, Personal Assistance 5,029 4,887 5,135 5,099
Average full-time employees, Elderly Care 954 820 895 862
Average full-time employees, Finland 1,619 1,681 1,654 1,669
Average full-time employees, Norway 960 779 932 838
Average full-time employees, Central Functions,
including Denmark
63 57 61 59
Total average full-time employees 10,731 10,309 10,746 10,592
Full-time employees at end of period 10,231 9,997 10,231 10,639
Average number of customers, Individual & Family 1,804 1,760 1,757 1,746
Average number of customers, Personal Assistance 1,878 1,885 1,891 1,893
Average number of customers, Elderly Care 837 803 833 825
Average number of customers, Finland 3,924 4,265 3,862 3,947
Average number of customers, Norway 358 312 328 317
Average number of customers, Denmark 67 69 68 68
Total average number of customers 8,868 9,094 8,739 8,795
Average number of shares for period, thousands 49,415 53,140 52,061 52,995
Equity per share, SEK 43 44 44 44
Earnings per share, SEK, after dilution 1.27 1.00 5.21 4.94

Parent Company

Condensed income statement

SEK millions Jan–Mar 2021 Jan–Mar 2020 Apr–Mar 2020/21 Jan–Dec 2020
Operating revenue 0 2 0 2
Operating expenses -5 -5 -17 -17
Operating profit -5 -3 -17 -15
Interest income 1 32 77 108
Interest expenses -41 -39 -110 -108
Profit after financial items -45 -10 -50 -15
Group contributions - - 105 105
Change in untaxed reserves - - 4 4
Profit before tax -45 -10 59 94
Income tax 9 2 -17 -25
Net profit for the period -36 -8 41 69

Condensed balance sheet

SEK millions 31 Mar 2021 31 Mar 2020 31 Dec 2020
Non-current assets 1,629 1,629 1,629
Current assets 1,401 1,921 1,616
TOTAL ASSETS 3,030 3,550 3,244
Equity 1,377 1,651 1,572
Untaxed reserves 148 152 148
Non-current interest-bearing liabilities 0 1,123 946
Other current liabilities 1,506 624 578
TOTAL EQUITY AND LIABILITIES 3,030 3,550 3,244

Notes

Note 1 Accounting policies

This interim report has been prepared in accordance with IAS 34 Interim Financial Reporting along with applicable stipulations in the Swedish Annual Accounts Act. The interim report for the Parent Company has been prepared in accordance with Chapter 9 of the Swedish Annual Accounts Act – Interim Reports. In general, the same accounting policies and bases of calculation have been used as in the annual report for 2020, which was prepared in accordance with the International Financial Reporting Standards as ratified by the EU, and interpretations of these.

Disclosures in accordance with IAS 34.16A appear in the financial statements and their associated notes as well as in the interim information on pages 2–8, which form an integral part of this financial report.

New accounting standards applied from 1 January 2021

Humana has made the assessment that new or amended standards and interpretations will not have any significant effect on the consolidated financial statements.

Note 2 Estimations and assessments

Preparation of interim financial statements in compliance with IFRS requires management to make accounting estimates and assumptions which affect the application of the accounting policies and the carrying amounts of assets, liabilities, income and expenses. The actual outcome may differ from these accounting estimates and assessments. The critical assessments and sources of uncertainty in estimates are the same as in the most recent annual report.

Note 3 Operating segments

Individual & Family Personal Assistance Elderly Care
SEK millions Jan–Mar
2021
Jan–Mar
2020
Jan–Mar
2021
Jan–Mar
2020
Jan–Mar
2021
Jan–Mar
2020
Net revenue – External income 553 519 751 719 151 146
Other operating revenue - - - - - -
Operating revenue 553 519 751 719 151 146
Profit before depreciation,
amortisation and other operating
expenses
50 42 50 41 8 3
Depreciation/amortisation -9 -8 0 0 -3 -3
Other operating expenses - -1 - - - -
Operating profit 41 33 50 40 5 0
Finland Norway Other Total
Jan–Mar Jan–Mar Jan–Mar Jan–Mar Jan–Mar Jan–Mar Jan–Mar Jan–Mar
SEK millions 2021 2020 2021 2020 2021 2020 2021 2020
Net revenue – External income 316 350 208 194 5 4 1,984 1,932
Other operating revenue 0 0 2 0 0 6 2 6
Operating revenue 316 350 210 194 5 10 1,986 1,938
Profit before depreciation,
amortisation and other 15 21 18 16 62 65 203 187
operating expenses
Depreciation/amortisation -4 -4 -2 -3 -73 -70 -91 -88
Other operating expenses - - - - - - - -1
Operating profit 11 17 17 13 -12 -5 112 98

Note 4 Revenue by country

SEK millions Jan–Mar
2021
Jan–Mar
2020
Sweden 1,455 1,390
Finland 316 350
Norway 210 194
Denmark 4 4
Total operating revenue 1,986 1,938

Note 5 Acquisitions

Net assets in acquired companies at date of acquisition

SEK millions Team J-son
Non-current assets 0
Current assets 27
Non-current liabilities -
Current liabilities -11
Net identifiable assets and liabilities 17
Goodwill 63
Total consideration 80
Contingent consideration -1
Consideration not yet settled -1
Cash and cash equivalents in acquired entities -20
Effect on cash and cash equivalents 58
Other
Settlement of considerations attributable to prior
acquisitions
1
Total effect on cash and cash equivalents 59

1)The acquisition analysis is preliminary as the final settlement has not been determined.

Humana's acquisitions in the first quarter 2021 increased the Group's revenue by SEK 15 million and had an effect of SEK 1 million on operating profit for the quarter. If the acquisition had occurred as at 1 January 2021, the consolidated revenue would have been SEK 1,993 million (SEK 7 million higher) and profit for the period would have been SEK 62,5 million (SEK 0,5 million lower).

Note 6 Fair value of financial instruments and level in valuation hierarchy

31 Mar 2021
SEK millions
Financial liabilities at
fair value through
profit or loss
Total carrying
amounts
Fair
values
Level 1 Level 2 Level 3
Financial liabilities
Earn-out payment 6 6 6 - - 6
31 Mar 2020 Financial liabilities at
fair value through
Total carrying Fair
SEK millions profit or loss amounts values Level 1 Level 2 Level 3
Financial liabilities
Earn-out payment 13 13 13 - - 13

Fair value measurement

When determining the fair value of an asset or liability, the Group uses observable data as far as possible. Fair value is categorised in various levels in a fair value hierarchy based on input data that is used in the valuation method as follows:

Level 1: according to prices quoted in an active market for the same instruments

Level 2: based on directly or indirectly observable market data that is not included in level 1

Level 3: inputs that are not observable in the market

Reconciliation of opening/closing balances for financial instruments measured in level 3, earn-out payment

SEK millions 31 Mar 2021 31 Dec 2020
Opening balance, 1 January 6 13
Total recognised gains and losses:
Recognised in adjustment of earn-out payments in net profit 0 0
Cost of acquisition 1 1
Settled during the period -1 -8
Closing balance, end of period 6 6

Hedge accounting

The Group is hedging parts of the foreign exchange risk related to net investments in foreign operations. As at 31 March 2021, the Group had exposure to EUR, NOK and DKK. DKK makes up a small amount and is not hedged. NOK and EUR are hedged using loans in foreign currency. Hedge accounting entails recognising the effective part of the translation differences in the consolidated statement of other comprehensive income. As at 31 March 2021, the Group had loans of EUR 40m and loans of NOK 328m for which hedge accounting is applied. The related translation difference of SEK -30m (7) before tax is consequently recognised in the consolidated statement of other comprehensive income.

Reconciliation of financial statements with IFRS

In the financial reports that Humana issues, there are alternative performance measures specified that complement the measurements defined or specified in the applicable financial reporting rules. Alternative performance measures are indicated when, in their context, they provide clearer or more detailed information than the measurements defined in the applicable financial reporting rules. Alternative performance measures derive from the company's consolidated accounts and are not measures in accordance with IFRS.

SEK millions Jan–Mar 2021 Jan–Mar 2020 Apr–Mar 2020/21 Jan–Dec 2020
Adjusted operating profit
Operating profit 112 98 485 471
Capital gain on sale of property 0 0 -17 -17
Adjusted operating profit 112 98 467 453
Adjusted EBITDA
Operating profit 112 98 485 471
Depreciation/amortisation 91 88 374 371
EBITDA 203 187 858 842
Capital gain on sale of property 0 0 -17 -17
Adjusted EBITDA 203 187 841 824
Organic revenue growth
Revenue, base 1,932 1,708 7,615 6,968
Revenue, organic growth 47 65 220 289
Total organic growth 2.4% 3.8% 2.9% 4.1%
Operating cash flow
Operating profit 112 98 485 471
Depreciation/amortisation 91 88 374 371
Change in working capital 23 -41 134 71
Investments in other non-current assets, net -29 -51 -111 -133
Operating cash flow 197 95 881 779
31 Mar 2021 31 Mar 2020 31 Dec 2020
Interest-bearing net debt
Non-current interest-bearing liabilities 1,970 3,695 3,457
Current interest-bearing liabilities 2,307 891 813
Cash and cash equivalents -589 -789 -759
Interest-bearing net debt 3,688 3,798 3,511
Adjusted EBITDA, 12 months 841 734 824
Interest-bearing net debt/Adjusted EBITDA, 12 months,
times
4.4x 5.2x 4.3x
Return on capital employed, %
Total assets 8,052 8,340 8,044
Deferred tax liabilities -72 -71 -70
Trade payables -111 -91 -128
Other current liabilities -1,310 -1,223 -1,222
Capital employed 6,559 6,955 6,624
Operating profit 112 98 471
Financial income 0 0 1
Total 112 99 471
Return on capital employed, % 1.7% 1.4% 7.1%
Equity/assets ratio, %
Total equity 2,282 2,368 2,354
Total assets 8,052 8,340 8,044
Equity/assets ratio, % 28.3% 28.4% 29.3%

Financial definitions and intent

Financial performance measures

Definition Intent
Return on
capital
employed (%)
Operating profit and financial income
divided by total capital employed
multiplied by 100.
Indicates the operating return on the capital that owners and
lenders have made available. The intent is to show
consolidated returns, regardless of the financing.
EBITDA Operating profit before depreciation,
amortisation and impairment.
The measure is used to monitor the company's profit/loss
generated by operating activities and facilitate comparisons of
profitability between different companies and industries.
Adjusted
operating profit
and adjusted
EBITDA
Operating profit and EBITDA adjusted
for items affecting comparability.
Adjustment for non-recurring items is made to facilitate a fair
comparison between two comparable periods and to show the
underlying trend in operating activities excluding non-recurring
items.
Operating cash
flow
Operating profit including changes in
depreciation/amortisation/impairment,
working capital and investments in
other assets (net).
The exclusion of cash flow from acquisitions and financing
facilitates an analysis of cash conversion in operating activities.
Organic growth Growth in local currency for comparable
companies in each segment that
Humana owned during the previous
comparative period.
The measure shows the underlying sales growth in comparable
companies between the different periods.
Interest
bearing net
debt
Borrowing excluding interest rate
derivatives less cash and cash
equivalents and interest-bearing assets.
Net debt is used as a simple way to illustrate and assess the
Group's ability to meet financial commitments.
Interest
bearing net
debt/adjusted
EBITDA
Interest-bearing net debt divided by
adjusted EBITDA.
The measure indicates consolidated debt in relation to adjusted
EBITDA. This is used to illustrate the Group's ability to meet
financial commitments.
Equity/assets
ratio (%)
Equity including non-controlling
interests divided by total assets
multiplied by 100.
Indicates the proportion of assets that are financed with
equity. The aim is to assess the Group's solvency in the long
term.
Capital
employed
Total assets less non-interest-bearing
liabilities.
The measure indicates the portion of the company's assets
financed by interest-bearing capital.

Other performance measures

Definition
Equity per share Equity attributable to Parent Company shareholders divided by number of shares
at end of period after redemption, buyback and new share issue.
Average number of shares Calculated as the average daily number of shares outstanding after redemption
and buyback.
Items affecting comparability Non-recurring items that complicate the comparability between two given
periods.
Average number of full-time
employees
Average number of full-time employees during the reporting period.
Average customers Average number of customers during the period.
Earnings per share for the period Profit for the period attributable to Parent Company shareholders less the
period's share of the adopted dividend divided by average number of shares.
Operating profit Profit before financial items and tax.
EBIT margin (%) Operating profit divided by operating revenue multiplied by 100.

This information is information that Humana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, on 6 May 2021 at 08:00 CET.

A web-based teleconference will be held on 6 May 2021 at 09:00 CET at which President and CEO Rasmus Nerman and CFO Noora Jayasekara will present the report and answer questions. To participate, call: SE: +46 8 5664 2693 UK: +44 33 3300 9260 US: +1 844 625 1570

Conference call Financial calendar Contact

2021 Annual General Meeting Half-year report Jan–Jun, Q2 2021 Interim report Jan–Sep, Q3 2021 11 May 2021 20 Aug 2021 11 Nov 2021

Noora Jayasekara, CFO +46 70 318 92 97 [email protected]

Anna Sönne, Head of Investor Relations and Sustainability +46 70 601 48 53 [email protected]

Humana AB Warfvinges väg 39, 7th fl. 112 51 Stockholm

Contact/information Telephone: +46 8-599 299 00 www.humanagroup.com